about
Update in genetic susceptibility in melanomaLineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.Detection of Exosomal miRNAs in the Plasma of Melanoma Patients.Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapyCharacterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.Genetics and epigenetics of melanoma.An ongoing role for Wnt signaling in differentiating melanocytes in vivoHigh incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.Genetics of melanoma progression: the rise and fall of cell senescence.Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.Melanocytic nevi and melanoma: unraveling a complex relationship.Dermoscopy in the era of dermato-oncology: from bed to bench side and retour.Focus on cutaneous and uveal melanoma specificities.Melanoma: a global perspective.The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma.Common Delayed Senescence of Melanocytes from Multiple Primary Melanoma PatientsThe MeLiM Minipig: An Original Spontaneous Model to Explore Cutaneous Melanoma Genetic Basis.Pathways from senescence to melanoma: focus on MITF sumoylation.Apoptotic Effect of Astragalin in Melanoma Skin Cancers via Activation of Caspases and Inhibition of Sry-related HMg-Box Gene 10.Pediatric melanoma: incidence, treatment, and prognosis.Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece.Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
P2860
Q26778756-A30821EA-7DB6-4FA0-9813-23365F606B85Q30829456-0D6AF245-5FC3-47A4-BF2E-A43A99BCAB8FQ36409368-0853DADE-4F4B-4A16-BAD2-0316F1D1D815Q36755569-D79DE6DA-F553-49E0-9A98-15BF3E03819CQ37083946-53E6CCFA-6573-4F96-A8CD-885DD752D42BQ37406812-AF970F26-FFBA-4039-B522-F7681FC20D29Q37714233-FB2B2591-2A44-4BF9-A978-A7D816CF659FQ38535596-3BF74114-2CAE-484D-B679-01DE0FD1B6EDQ38589518-11ED301D-1113-4E96-B682-5C0D048616DAQ38691170-AC2646A1-C3E8-46E2-BF74-0C24516DBD10Q38730348-466DE849-873E-4C40-B9D8-C0CCBE0C33BCQ38783355-D5E6D877-D6BE-46DF-B40A-A4A81453B73EQ39312161-05B02A46-8679-4CC1-B2ED-E716239C7DBEQ40224378-D512CF66-5F0C-40DF-B0B1-2B4D5897D457Q41115366-A743333D-2140-4F8C-9D7D-37C5F7BAECECQ42111608-A671675F-4ECB-4A2B-9E5B-B79DA5AC6802Q45955388-7C36354B-56E5-41E8-8213-D140EE5091F7Q47927484-67DB3CCA-27CD-40DA-9C5D-5D2E0045933CQ48238068-FA5EA952-247B-4C6C-9F66-63ECB84C6F47Q49480419-9D04163F-80B7-4612-83F9-D42C0DB6879CQ54116561-5C36B711-E175-4B8F-84C6-9A9B5875F381Q55397223-F165E016-AC93-491F-852E-FAB1C9B377FEQ57044361-6B2C1618-4535-44EE-ABC1-E841DF7AB5F0
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetics of familial melanoma: 20 years after CDKN2A.
@ast
Genetics of familial melanoma: 20 years after CDKN2A.
@en
Genetics of familial melanoma: 20 years after CDKN2A.
@nl
type
label
Genetics of familial melanoma: 20 years after CDKN2A.
@ast
Genetics of familial melanoma: 20 years after CDKN2A.
@en
Genetics of familial melanoma: 20 years after CDKN2A.
@nl
prefLabel
Genetics of familial melanoma: 20 years after CDKN2A.
@ast
Genetics of familial melanoma: 20 years after CDKN2A.
@en
Genetics of familial melanoma: 20 years after CDKN2A.
@nl
P2093
P2860
P356
P1476
Genetics of familial melanoma: 20 years after CDKN2A.
@en
P2093
Karin A W Wadt
Lauren G Aoude
Nicholas K Hayward
P2860
P304
P356
10.1111/PCMR.12333
P577
2015-01-05T00:00:00Z